The Newswire

Your daily serving of financial goodness

Income Investors Eye Duxton Water IPO

Income Investors Eye Duxton Water IPO
The portfolio of water rights is forecasted to deliver a weighted average gross yield of 5.9%, with potential scope for capital growth over the long-term.
Sep 12, 2016 By Simon Herrmann Tags: IPO, D2O

Duxton Water Limited is an Australian investment company focused on water investments. The company owns a portfolio of “Australian Water Entitlements”, which the company leases to producers, who in return pay annual rent to the Company. At completion of the offer, Duxton Water will own and manage an initial Water Entitlement Portfolio valued at $38 million. The company seeks to raise $99 million by issuing 90 million shares at $1.10.

The portfolio of water rights is forecasted to deliver a weighted average gross yield of 5.9%, with potential scope for capital growth over the long-term. Upon settlement over 88% of the existing portfolio will be leased back and the company intends to declare the first dividend within the first 12 months of listing. Income visibility is high with an average lease term of 7 years.

However, the company carries a concentration risk as its entire portfolio is invested in Australian Water Entitlements. Water price indices have been rising for the past four years and there is a risk that this may present a cyclical peak. Lease concentration is high as upon listing ~86% of lease revenue is being paid by one lessee Duxton Viticulture.

The listing offers investors the ability to gain exposure to the Australian water market, which has historically shown a low correlation to high risk asset classes. Capital growth will depend on rising water prices, which is not assured. While capital growth may be limited we believe that the IPO provides an attractive income opportunity to investors looking for yield.

Company: Duxton Water Limited
ASX Code: D2O
Shares on Offer: 90m
Listing Price: $1.10
Market Capitalisation: 127.7m
Listing Date: September 21

 

Share this article

Simon Herrmann Author: Simon Herrmann Sep 12, 2016

Simon is a financial analyst at independent research firm Wise-owl who wants to change the world by disrupting the cliché approach to investment decision making with convergent thinking. Wise-owl’s goal is plain and simple: Find the best opportunities for our members by following a proven methodology and to create long-term value through high-quality advice, innovation, technology and education. We combine industry experience and the agile mentality of a start-up. Wise-owl is the future of stock market investing.


Interested in IPOs? Bid directly here:

Loading...
Disclaimer: Clicking on this link will take you to a third-party website. We do not control or give advice regarding the content or links that appear on these sites and Wise-owl accepts no responsibility or liability in respect of any third party materials. Wise-owl may earn a commission from any product or service from third party websites.

Growing Cases of Cancer Fuel Demand for Diagnostic Technology: Sienna Cancer IPO

The Australian government estimates that over 130,000 new cancer cases will be diagnosed in 2017 and the risk of individuals dying from cancer by their 85th birthday will be one in five.

Author: Simon Herrmann Jun 23, 2017

Errors

Sign Up for Free Trial
Subscribe
Recent Tweets
Recent News